about
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States a...
Read More
7.69
-0.09
(-1.16%)
812.4K
XNAS Volume
XNAS 23 Sep, 2026 5:30 PM (EDT)
Low Financial Strength
Affordable Valuation
Technically Neutral
Risky Value
These stocks have weak financials and average momentum. They may be affordable, but investors should exercise caution
View Similar
Embed DVM
CorMedix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..